Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Workiva
WK
$3.84B
| $14.1M | ﹤0.01% |
137,248
+39,620
| +41% | +$3.59M |
|
2302
Golar LNG
GLNG
$5.36B
| $14.1M | ﹤0.01% |
650,465
-50,289
| -7% | -$1.13M |
|
2303
Helmerich & Payne
HP
$4.42B
| $14M | ﹤0.01% |
392,797
+30,057
| +8% | +$1.3M |
|
2304
PUT
STMicroelectronics
STM
$48.5B
| $14M | ﹤0.01% |
262,300
-8,900
| -3% | -$415K |
|
2305
iShares Russell 1000 Value ETF
IWD
$84.2B
| $14M | ﹤0.01% |
92,139
-6,928
| -7% | -$1.07M |
|
2306
Karyopharm Therapeutics
KPTI
$45.8M
| $14M | ﹤0.01% |
240,164
-7,380
| -3% | -$364K |
|
2307
CALL
Vanguard Total World Stock ETF
VT
$81.8B
| $14M | ﹤0.01% |
152,100
+47,500
| +45% | +$4.3M |
|
2308
Valvoline
VVV
$4.36B
| $14M | ﹤0.01% |
400,644
-254,162
| -39% | -$8.84M |
|
2309
CALL
NCR Voyix
VYX
$1.13B
| $14M | ﹤0.01% |
967,079
-193,481
| -17% | -$2.97M |
|
2310
Atkore
ATKR
$3.17B
| $14M | ﹤0.01% |
99,617
-148,568
| -60% | -$20.1M |
|
2311
HSBC
HSBC
$356B
| $14M | ﹤0.01% |
409,919
-877,381
| -68% | -$31.5M |
|
|
AGR
2312
DELISTED
Avangrid, Inc.
AGR
| $14M | ﹤0.01% |
350,788
+269,742
| +333% | +$11M |
|
2313
PUT
Citizens Financial Group
CFG
$31.5B
| $14M | ﹤0.01% |
460,400
+55,700
| +14% | +$2.18M |
|
2314
Cogent Biosciences
COGT
$6.58B
| $14M | ﹤0.01% |
1,295,772
-558,548
| -30% | -$7.14M |
|
|
OSH
2315
CALL
DELISTED
Oak Street Health, Inc.
OSH
| $14M | ﹤0.01% |
361,400
-10,600
| -3% | -$342K |
|
2316
CALL
Intercontinental Exchange
ICE
$86.9B
| $14M | ﹤0.01% |
134,000
-25,500
| -16% | -$2.66M |
|
2317
CALL
Novavax
NVAX
$1.33B
| $14M | ﹤0.01% |
2,015,200
+76,400
| +4% | +$703K |
|
2318
Hyatt Hotels
H
$17.1B
| $14M | ﹤0.01% |
124,914
-433,527
| -78% | -$47.5M |
|
2319
Wendy's
WEN
$1.65B
| $13.9M | ﹤0.01% |
640,063
+528,275
| +473% | +$11.6M |
|
2320
Silicon Motion
SIMO
$9.12B
| $13.9M | ﹤0.01% |
212,701
+118,501
| +126% | +$7.78M |
|
2321
GDS Holdings
GDS
$6.89B
| $13.9M | ﹤0.01% |
746,515
+689,309
| +1,205% | +$14.6M |
|
2322
CALL
Genuine Parts
GPC
$18.6B
| $13.9M | ﹤0.01% |
83,100
-52,500
| -39% | -$8.85M |
|
2323
AdaptHealth
AHCO
$775M
| $13.9M | ﹤0.01% |
1,117,681
+809,152
| +262% | +$14.9M |
|
2324
IDEAYA Biosciences
IDYA
$3.49B
| $13.9M | ﹤0.01% |
1,011,116
+124,257
| +14% | +$2.07M |
|
2325
Xerox
XRX
$407M
| $13.9M | ﹤0.01% |
899,842
+524,136
| +140% | +$8.47M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.